CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities
Net income	$ 22,343	$ 26,501
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation, amortization and share-based compensation	3,527	1,640
Net realized gains on investment	(357)	(885)
Foreign exchange losses	2,407	1,921
Changes in assets – (increase) decrease:
Reinsurance balances receivable, net	(201,674)	(204,287)
Reinsurance recoverable on unpaid losses	3,187	(8,792)
Accrued investment income	(880)	386
Deferred commission and other acquisition expenses	(35,908)	(47,280)
Other assets	5,809	(6,461)
Changes in liabilities – increase (decrease):
Reserve for loss and loss adjustment expenses	55,463	89,175
Unearned premiums	152,214	193,550
Accrued expenses and other liabilities	(38,272)	9
Net cash (used in) provided by operating activities	(32,141)	45,477
Cash flows from investing activities:
Purchases of fixed-maturities – available-for-sale	(263,873)	(118,935)
Purchases of other investments	0	(120)
Proceeds from sales of fixed-maturities – available-for-sale	148,782	30,784
Proceeds from maturities, paydowns and calls of fixed maturities – available-for-sale	113,235	105,181
Proceeds from maturities and calls of fixed maturities – held to maturity	25,188	0
Proceeds from sale and redemption of other investments	275	266
Other, net	(1,579)	(367)
Net cash provided by investing activities	22,028	16,809
Cash flows from financing activities:
Issuance of common shares	0	518
Repurchase of common shares	(193)	(575)
Dividends paid – Maiden common shareholders	(12,452)	(12,948)
Dividends paid – preference shares	(8,545)	(6,033)
Net cash used in financing activities	(21,190)	(19,038)
Effect of exchange rate changes on foreign currency cash and cash equivalents and restricted cash and cash equivalents	837	451
Net (decrease) increase in cash and cash equivalents and restricted cash and cash equivalents	(30,466)	43,699
Cash and cash equivalents and restricted cash and cash equivalents, beginning of period	191,503	149,535
Cash and cash equivalents and restricted cash and cash equivalents, end of period	161,037	193,234
Total cash and cash equivalents, and restricted cash and cash equivalents shown in the Condensed Consolidated Statements of Cash Flows, end of period	$ 191,503	$ 149,535